Loading...
01/11 03:10
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary shows strong financial metrics with optimistic guidance, particularly in Integrated Care revenue growth. While BetterHelp faces a revenue decline, new initiatives like insurance could offset this. The Q&A session indicates positive analyst sentiment, with management addressing concerns about customer acquisition and integration strategies. Announcements of strategic priorities and operational excellence further bolster confidence. Given the market cap, the stock is likely to see a positive movement of 2% to 8%.
Consolidated Revenue $626 million, declined 2.2% year-over-year. The decline was due to growth in the Integrated Care segment being offset by a decline at BetterHelp.
Adjusted EBITDA $70 million, representing an 11.2% margin. This was at the high end of the guidance range, reflecting disciplined execution across the business.
Net Loss Per Share $0.28, which included a noncash goodwill impairment charge of $0.07 per share pretax. The impairment charge was triggered by the carrying value of the Integrated Care reporting unit exceeding its fair value.
Free Cash Flow $68 million in the third quarter, bringing year-to-date free cash flow to $113 million. This reflects strong liquidity and operational performance.
Integrated Care Revenue $390 million, up 1.5% year-over-year. Growth was driven by mid-teens growth in the international business on a constant currency basis and contributions from the acquisitions of Catapult and Telecare.
Chronic Care Program Enrollment 1.17 million, grew 4% sequentially, adding 48,000 lives. This marks a return to sequential growth.
BetterHelp Revenue $236.9 million, included approximately $4 million in insurance revenue. Average paying users declined 4% year-over-year, with high single-digit growth in non-U.S. users partially offsetting a high single-digit decline in U.S. users.
BetterHelp Adjusted EBITDA $4 million, representing a margin of 1.6%. The decline was driven by lower revenue and investments to support the insurance rollout, partly offset by lower ad spend.
International Integrated Care Revenue Grew 14% year-over-year on a constant currency basis. Growth was supported by the acquisition of Telecare and strong performance in the international business.
Prism care delivery platform enhancements: Improved ability to surface important information at the point of care, address gaps in care, manage referrals, and activate relevant programs based on member needs. Embedded provider-to-provider specialist consults enhance care resolution and cost savings.
Chronic care innovations: Developing AI-enabled risk evaluation and stratification models for high-risk populations. Active pilots underway with plans to launch in 2026.
Catapult integration: Expanded capabilities for early member engagement through health screenings, at-home diagnostic testing, and clinical support. Strong client interest observed.
Wellbound employee assistance program: New offering leveraging integrated care and BetterHelp capabilities. Early strong interest and pipeline growth.
BetterHelp insurance rollout: Launched in 7 states and the District of Columbia, with plans for further expansion in 2025. Early metrics align with expectations, including user growth and session rates.
International Integrated Care growth: 14% year-over-year revenue growth on a constant currency basis. Expansion in Australia through the acquisition of Telecare, targeting deeper penetration in the public health sector.
ISO 9001 certification: Achieved for key processes within U.S. Integrated Care, reflecting high-quality client and member experience.
Cost efficiencies: Improvements in technology, development, administrative costs, and share-based compensation. Continued focus on streamlining cost structure into 2026.
Shift to fee-for-service revenue model: Visit-based revenues now comprise over 50% of U.S. virtual care revenues, up from 40% in 2023. Anticipated moderation in revenue impact going forward.
BetterHelp non-U.S. growth: High single-digit user growth in non-U.S. markets, supported by localized market launches.
Fee-for-service revenue model shift: The shift towards fee-for-service revenue models in virtual care, which now comprises over 50% of U.S. virtual care revenues, may lead to revenue volatility and potential challenges in maintaining consistent revenue growth.
BetterHelp U.S. cash pay business decline: The U.S. cash pay business for BetterHelp is experiencing high single-digit declines due to weaker consumer sentiment, macroeconomic uncertainty, and growing consumer preference for insurance-covered mental health benefits.
Insurance rollout challenges: The rollout of BetterHelp's insurance offering is in its early stages and requires significant investment, which could strain financial resources and delay profitability.
Tariff-related cost pressures: Tariff-related developments are creating a $3 million headwind to adjusted EBITDA, with potential for further impact if alternative sourcing arrangements are not successfully implemented.
Goodwill impairment: A noncash goodwill impairment charge of $0.07 per share pretax was recorded, indicating potential overvaluation of certain assets and impacting financial results.
Chronic care enrollment growth: While chronic care program enrollment grew 4% sequentially, the growth rate remains modest, which could limit the segment's contribution to overall revenue growth.
International expansion risks: Expansion into international markets, including the acquisition of Telecare in Australia, involves integration risks and potential challenges in achieving expected growth and profitability.
Operational cost pressures: Efforts to streamline costs, including technology, development, and administrative expenses, may face challenges in achieving further efficiencies without impacting service quality.
Macroeconomic uncertainties: Weaker consumer sentiment and macroeconomic uncertainties are affecting user growth and revenue, particularly in the U.S. market.
Integrated Care Revenue Growth: For 2025, Integrated Care revenue is expected to grow by 2.4% to 3.5% over 2024, with the midpoint of the range raised by 40 basis points compared to prior guidance. This includes contributions from the Telecare acquisition and strong year-to-date performance.
BetterHelp Insurance Rollout: The insurance rollout is expected to generate $12 million to $14 million in total revenue for 2025. Early launches in seven states, including Florida, Texas, and New York, have shown promising results, with further state expansions planned for the remainder of 2025.
BetterHelp Revenue and Adjusted EBITDA: BetterHelp's full-year revenue is expected to decline by 8% to 9.2% year-over-year, reflecting challenges in the U.S. cash pay business. Adjusted EBITDA margin for BetterHelp is projected to be between 3.8% and 4.6% for 2025, with sequential margin improvement expected in Q4 due to reduced advertising spend.
Consolidated Revenue and Adjusted EBITDA: For 2025, consolidated revenue is projected to be between $2.510 billion and $2.539 billion, with adjusted EBITDA expected to range from $270 million to $287 million. Free cash flow is anticipated to be between $170 million and $185 million.
Chronic Care Innovations: New clinical intervention models for rising and high-risk populations are being developed, leveraging AI-enabled risk evaluation and stratification. These innovations are expected to launch in 2026.
International Integrated Care Growth: International Integrated Care revenue grew 14% year-over-year in Q3 2025 on a constant currency basis. Continued growth opportunities are anticipated, including expansion in Australia through the Telecare acquisition.
Operational Excellence and Cost Efficiencies: Cost efficiencies are being pursued across expense categories and capital expenditures, with a focus on streamlining operations into 2026.
The selected topic was not discussed during the call.
The earnings call summary shows strong financial metrics with optimistic guidance, particularly in Integrated Care revenue growth. While BetterHelp faces a revenue decline, new initiatives like insurance could offset this. The Q&A session indicates positive analyst sentiment, with management addressing concerns about customer acquisition and integration strategies. Announcements of strategic priorities and operational excellence further bolster confidence. Given the market cap, the stock is likely to see a positive movement of 2% to 8%.
The earnings call presents a mixed picture: while there are headwinds in the BetterHelp segment and uncertainty in margins, there are positive developments such as international growth and strategic partnerships. The Q&A section reveals analysts' concerns about competitive pressures and unclear management responses, particularly in the insurance rollout and growth trajectory. The overall sentiment is balanced by strategic initiatives and the potential for future growth, leading to a neutral stock price prediction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
